Clinical trials recruiting in Bakirkoy / Istanbul, Turkey (Türkiye)
4
Recruiting trials
4
Conditions
Phase breakdown
Phase 2 1Phase 3 4
Conditions recruiting in Bakirkoy / Istanbul, Turkey (Türkiye)
| Condition | Trials |
|---|---|
| Breast Cancer | 4 |
| Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 1 |
| HER2-positive Breast Cancer | 1 |
| Metastatic Breast Cancer | 1 |
Recruiting trials in Bakirkoy / Istanbul, Turkey (Türkiye)
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Common questions
How many clinical trials are recruiting in Bakirkoy / Istanbul, Turkey (Türkiye)?
4 recruiting trials have at least one study site in Bakirkoy / Istanbul, Turkey (Türkiye).
Is this list complete?
No. For the full record, search ClinicalTrials.gov.